Bupropion and other non-nicotine pharmacotherapies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Efficacy of bupropion in the indigenous Maori population in New Zealand.Thorax · 2005
   Trial
2. Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.American journal of translational research · 2025
   Review
3. Obstructive Sleep Apnea and Smoking Increase the Risk of Cardiovascular Disease: Smoking Cessation Pharmacotherapy.Journal of clinical medicine · 2023
   Review
4. Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review.BMJ open · 2022
   Article
5. Effectiveness of stop smoking interventions among adults: protocol for an overview of systematic reviews and an updated systematic review.Systematic reviews · 2019
   Article
6. Effectiveness of pharmacotherapy for smoking cessation: protocol for umbrella review and quality assessment of systematic reviews.Systematic reviews · 2018
   Article
7. Review of pharmacotherapy for smoking cessation in patients with schizophrenia.The mental health clinician · 2018
   Review
8. Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation.BMC public health · 2015
   Article
9. Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.Multidisciplinary respiratory medicine · 2014
   Article
10. Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders.Frontiers in neuroscience · 2014
    Review
11. Pharmacological intervention of nicotine dependence.BioMed research international · 2013
    Review
12. Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.British journal of pharmacology · 2012
    Review
13. Tobacco smoking: patterns, health consequences for adults, and the long-term health of the offspring.Global journal of health science · 2012
    Article
14. Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.Drug safety · 2012
    Article
15. Smoking cessation therapy with varenicline.International journal of chronic obstructive pulmonary disease · 2008
    Review
16. Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort.British journal of clinical pharmacology · 2007
    Article
17. Smoking cessation.BMJ (Clinical research ed.) · 2006
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as